- Home
- TLSA vs ORMP Comparison
TLSA vs ORMP Comparison
Compare TLSA & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- ORMP
- Stock Information
- Founded
- TLSA 2013
- ORMP 2002
- Country
- TLSA United Kingdom
- ORMP United States
- Employees
- TLSA N/A
- ORMP N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- TLSA Health Care
- ORMP Health Care
- Exchange
- TLSA Nasdaq
- ORMP Nasdaq
- Market Cap
- TLSA 87.8M
- ORMP 84.3M
- IPO Year
- TLSA 2000
- ORMP N/A
- Fundamental
- Price
- TLSA $1.53
- ORMP $2.37
- Analyst Decision
- TLSA
- ORMP Hold
- Analyst Count
- TLSA 0
- ORMP 1
- Target Price
- TLSA N/A
- ORMP N/A
- AVG Volume (30 Days)
- TLSA 1.4M
- ORMP 253.5K
- Earning Date
- TLSA 03-18-2025
- ORMP 03-18-2025
- Dividend Yield
- TLSA N/A
- ORMP N/A
- EPS Growth
- TLSA N/A
- ORMP N/A
- EPS
- TLSA N/A
- ORMP 0.11
- Revenue
- TLSA N/A
- ORMP N/A
- Revenue This Year
- TLSA N/A
- ORMP N/A
- Revenue Next Year
- TLSA N/A
- ORMP N/A
- P/E Ratio
- TLSA N/A
- ORMP $23.94
- Revenue Growth
- TLSA N/A
- ORMP N/A
- 52 Week Low
- TLSA $0.41
- ORMP $1.96
- 52 Week High
- TLSA $1.91
- ORMP $3.14
- Technical
- Relative Strength Index (RSI)
- TLSA 63.64
- ORMP 57.36
- Support Level
- TLSA $1.25
- ORMP $2.42
- Resistance Level
- TLSA $1.59
- ORMP $2.68
- Average True Range (ATR)
- TLSA 0.24
- ORMP 0.15
- MACD
- TLSA 0.03
- ORMP 0.05
- Stochastic Oscillator
- TLSA 57.80
- ORMP 70.83
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.